Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
failed trials
Pharma
Gilead pulls Trodelvy in bladder cancer after trial flop
Gilead said it will pull Trodelvy's accelerated approval in bladder cancer after consultation with the FDA.
Angus Liu
Oct 18, 2024 10:18am
Aadi lays off 80% of R&D workforce as Fyarro heads to ph. 2 fail
Aug 21, 2024 4:51am
Gilead's Trodelvy suffers double whammy
May 30, 2024 6:20pm
ASCO: Merck KGaA's Bavencio combo misses survival mark in RCC
May 23, 2024 5:00pm
ASCO: Lilly seeks prostate cancer redemption after Verzenio flop
May 23, 2024 5:00pm
Bristol Myers fails to beat AZ in stage 3 lung cancer
May 13, 2024 10:23am
